Quarterly report pursuant to Section 13 or 15(d)

Noncontrolling Interest

v3.19.3
Noncontrolling Interest
9 Months Ended
Sep. 30, 2019
Noncontrolling Interest [Abstract]  
NONCONTROLLING INTEREST

NOTE 14 – NONCONTROLLING INTEREST

 

As of September 30, 2019, Dr. Yu Zhou, a director and former Co-Chief Executive Officer of Genexosome, who owns 40% of the equity interests of Genexosome, which is not under the Company's control. The following is a summary of noncontrolling interest activities in the nine months ended September 30, 2019.

 

Noncontrolling interest at December 31, 2018   $ (862,200 )
Net loss attributable to noncontrolling interest     (656,575 )
Foreign currency translation adjustment attributable to noncontrolling interest     5,154  
Noncontrolling interest at September 30, 2019   $ (1,513,621 )